Table 2.
Changes in hemodynamic parameters in patient 1
| Patient 1 | Before levosimendan | After 48 h since levosimendan infusion |
|---|---|---|
| Systolic pressure | 52.0 (49.0–54.0) | 64 (60.0–66.0) |
| Diastolic pressure | 25.0 (24.0–27.0) | 38.0 (34.0–44.0) |
| Dicrotic pressure | 24.0 (23.0–26.0) | 30.0 (28.0–31.0) |
| Pulse rate | 155 (148–159) | 154 (135–158) |
| CI | 2.05 (1.94–2.29) | 2.90 (2.53–3.04) |
| DO2I | 354 (334–403) | 495 (431–518) |
| Cerebral FTOE | 0.48 (0.41–0.53) | 0.51 (0.45–0.56) |
| Renal FTOE | 0.31 (0.22–0.46) | 0.62 (0.49–0.72) |
CI: cardiac index; DO2I: oxygen diffusion index; FTOE: fractional tissue oxygen extraction